Angela Arancio

Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART

Barbara Ensoli, Stefania Bellino, Antonella Tripiciano et al. · PLoS ONE · 2010 · 95 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up

Olimpia Longo, Antonella Tripiciano, Valeria Fiorelli et al. · Vaccine · 2009 · 54 citations

Life Sciences, Immunology, Molecular Biology +9

The preventive phase I trial with the HIV-1 Tat-based vaccine

Barbara Ensoli, Valeria Fiorelli, Fabrizio Ensoli et al. · Vaccine · 2009 · 54 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial

Fabrizio Ensoli, Aurelio Cafaro, Anna Casabianca et al. · Retrovirology · 2015 · 50 citations · Full text

Medicine, Immunology, Infectious Diseases +17

The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study

Stefania Bellino, Antonella Tripiciano, Orietta Picconi et al. · Retrovirology · 2014 · 44 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17